Investors Buy Shares of SPDR S&P Biotech Etf (Xbi) on Weakness

Investors Buy Shares of SPDR S&P Biotech Etf (Xbi) on Weakness


Investors bought shares of SPDR S&P Biotech ETF on weakness during trading on Wednesday. $147.17 million flowed into the stock on the tick-up and $108.17 million flowed out of the stock on the tick-down, for a money net flow of $39.00 million into the stock.



from Biotech News